Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Legislation Introduced To Tackle California's GPCI Problem, Raise Medicare Rates In Certain High-Cost Counties
U.S. Rep. Sam Farr (D-Calif.) and Sen. Dianne Feinstein (D-Calif.) introduced legislation sponsored by the California Medical Association to eliminate one of the biggest barriers for seniors to get access to health care - low Medicare reimbursement rates in several counties.
generic viagra online
European Travellers Continue To Put Their Health At Risk
European travellers are still putting their health at risk says the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), with one third experiencing travel-related illness when visiting abroad. On a typical two-week trip, travellers lose an average of three days due to illness - almost 20 percent of them remain ill after their return home, and another 10 percent need medical care.
News of the day
What Is Typhoid Fever? What Is Typhoid?
Typhoid fever is an infectious disease caused by the bacteria Salmonella typhi. It is also known as enteric fever, or commonly just typhoid. Typhoid fever and paratyphoid fever are clinically indistinguishable diseases, collectively called enteric fever. It easily spreads through contaminated food and water supplies and close contact with others who are infected. The illness is characterized by very high fever, sweating, gastroenteritis, and diarrhea. Although typhoid is very rare in the developed world, it is still a serious health threat in the developing world. Typhoid is treatable with antibiotics.
Health Insurance

WHO Approves Second HPV Vaccine

The WHO announced Thursday it had approved a second cervical cancer vaccine, opening "U.N. agencies and partners [to] now officially buy millions of doses of the vaccine for poor countries worldwide," where an estimated 80 percent of the 280,000 annual deaths from cervical cancer occur each year, the AP/Google.com reports (7/9). Cervarix, produced by GlaxoSmithKline (GSK), prevents HPV infection, which can cause cervical cancer. Cervarix, joins Merck"s Gardasil, in receiving the "green light" from the WHO, Reuters reports. "WHO "prequalification" is necessary for U.N. agencies and the non-profit GAVI Alliance to purchase the vaccine, and Glaxo said on Thursday it hoped the move would help speed access to Cervarix globally," Reuters writes (Hirschler, 7/9) - which officials say will save "tens of thousands of lives," according to AP/Google.com (7/9). "We"re very eager to offer women in developing countries these vaccines because without early screening, they are arguably more vulnerable to cervical cancer," Dan Thomas, a spokesman for GAVI, said, according to Reuters (7/9). However, cost arrangements have yet to be settled, Dow Jones Newswires/Wall Street Journal reports (Stovall, 7/9). Reuters reports that GAVI is in talks with GSK and Merck in hopes of bringing the cost of the vaccine down for developing countries (7/9). AP/Google.com writes: "In the West, the vaccines typically cost about $360 for a three-shot dose - which is far too expensive for poor countries, Thomas said" (7/9). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009